A new breast cancer drug trialled at the Christie Hospital in Manchester could offer a lineline for women with the most aggressive form of the disease.
The drug, known as T-DM1, has been shown to increase the survival time of some patients by almost six months.
It also reduced side effects such as hair loss and gives sufferers a better quality of life.
More top news
Charity Shelter release photos of North West slums in attempt to identify some of the people in them to celebrate its 50th anniversay
Thousands of junior doctors across England are going on strike after last-ditch talks failed to reach an agreement.
Coronation Street star Paula Lane is leaving the show after six years playing troubled Kylie Platt.